Bionano Genomics, Inc. Research and Development Expense
Bionano Genomics, Inc. (BNGO) reported Research and Development Expense of $2.99 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-10
- Bionano Genomics, Inc. research and development expense for the quarter ending 2026-06-30 was $2.99M, a 1.94% increase year-over-year.
- Bionano Genomics, Inc. research and development expense for the quarter ending 2026-03-31 was $3.14M, a 32.45% increase year-over-year.
- Bionano Genomics, Inc. research and development expense for the quarter ending 2025-12-31 was $3.23M, a 7.05% decline year-over-year.
- Bionano Genomics, Inc. research and development expense for the quarter ending 2025-09-30 was $2.84M, a 39.71% decline year-over-year.
- Bionano Genomics, Inc. research and development expense for fiscal 2025 was $11.37M, a 54.14% decline from fiscal 2024.
- Bionano Genomics, Inc. research and development expense for fiscal 2024 was $24.80M, a 54.10% decline from fiscal 2023.
- Bionano Genomics, Inc. research and development expense for fiscal 2023 was $54.03M, a 10.16% increase from fiscal 2022.
- Bionano Genomics, Inc. research and development expense for fiscal 2022 was $49.05M, a 118.13% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.99M 10-Q · filed 2026-08-10 | $6.13M 10-Q · filed 2026-08-10 | $9.36M derived: sum of 3 quarters · filed 2026-08-10 | $12.20M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | $3.14M 10-Q · filed 2026-05-13 | $6.37M derived: sum of 2 quarters · filed 2026-05-13 | $9.21M derived: sum of 3 quarters · filed 2026-05-13 | $12.14M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | $3.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $6.07M derived: sum of 2 quarters · filed 2026-03-23 | $9.00M derived: sum of 3 quarters · filed 2026-08-10 | $11.37M 10-K · filed 2026-03-23 | ||||
| 2025-09-30 | $2.84M 10-Q · filed 2025-11-13 | $5.78M derived: sum of 2 quarters · filed 2026-08-10 | $8.14M 10-Q · filed 2025-11-13 | $11.62M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | $2.93M 10-Q · filed 2026-08-10 | $5.30M 10-Q · filed 2026-08-10 | $8.78M derived: sum of 3 quarters · filed 2026-08-10 | $13.49M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | $2.37M 10-Q · filed 2026-05-13 | $5.84M derived: sum of 2 quarters · filed 2026-05-13 | $10.56M derived: sum of 3 quarters · filed 2026-05-13 | $17.39M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $3.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $8.19M derived: sum of 2 quarters · filed 2026-03-23 | $15.02M derived: sum of 3 quarters · filed 2026-03-23 | $24.80M 10-K · filed 2026-03-23 | ||||
| 2024-09-30 | $4.72M 10-Q · filed 2025-11-13 | $11.55M derived: sum of 2 quarters · filed 2025-11-13 | $21.33M 10-Q · filed 2025-11-13 | $33.03M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $6.83M 10-Q · filed 2025-08-14 | $16.61M 10-Q · filed 2025-08-14 | $28.31M derived: sum of 3 quarters · filed 2025-08-14 | $42.10M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $9.78M 10-Q · filed 2025-05-14 | $21.48M derived: sum of 2 quarters · filed 2025-05-14 | $35.27M derived: sum of 3 quarters · filed 2025-05-14 | $49.88M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $11.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $25.49M derived: sum of 2 quarters · filed 2025-03-31 | $40.10M derived: sum of 3 quarters · filed 2025-03-31 | $54.03M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $13.79M 10-Q · filed 2024-11-14 | $28.39M derived: sum of 2 quarters · filed 2024-11-14 | $42.33M 10-Q · filed 2024-11-14 | $56.34M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $14.61M 10-Q · filed 2024-08-07 | $28.55M 10-Q · filed 2024-08-07 | $42.56M derived: sum of 3 quarters · filed 2024-08-07 | $55.30M derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2023-03-31 | $13.94M 10-Q · filed 2024-05-08 | $27.95M derived: sum of 2 quarters · filed 2024-05-08 | $40.69M derived: sum of 3 quarters · filed 2024-05-08 | $52.46M derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | $14.01M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $26.75M derived: sum of 2 quarters · filed 2024-03-05 | $38.52M derived: sum of 3 quarters · filed 2024-03-05 | $49.05M 10-K · filed 2024-03-05 | ||||
| 2022-09-30 | $12.74M 10-Q · filed 2023-11-08 | $24.51M derived: sum of 2 quarters · filed 2023-11-08 | $35.04M 10-Q · filed 2023-11-08 | $44.25M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | $11.77M 10-Q · filed 2023-08-09 | $22.30M 10-Q · filed 2023-08-09 | $31.51M derived: sum of 3 quarters · filed 2023-08-09 | $38.01M derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | $10.53M 10-Q · filed 2023-05-09 | $19.74M derived: sum of 2 quarters · filed 2023-05-09 | $26.25M derived: sum of 3 quarters · filed 2023-05-09 | $30.33M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | $9.21M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $15.72M derived: sum of 2 quarters · filed 2023-03-09 | $19.81M derived: sum of 3 quarters · filed 2023-03-09 | $22.48M 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | $6.50M 10-Q · filed 2022-11-03 | $10.59M derived: sum of 2 quarters · filed 2022-11-03 | $13.27M 10-Q · filed 2022-11-03 | $16.15M derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | $4.09M 10-Q · filed 2022-08-04 | $6.76M 10-Q · filed 2022-08-04 | $9.64M derived: sum of 3 quarters · filed 2022-08-04 | $11.95M derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | $2.68M 10-Q · filed 2022-05-05 | $5.55M derived: sum of 2 quarters · filed 2022-05-05 | $7.86M derived: sum of 3 quarters · filed 2022-05-05 | $10.26M derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | $2.88M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $5.18M derived: sum of 2 quarters · filed 2022-03-01 | $7.58M derived: sum of 3 quarters · filed 2022-03-01 | $10.26M 10-K · filed 2022-03-01 | $10.26M 10-K · filed 2021-03-23 | |||
| 2020-09-30 | $2.30M 10-Q · filed 2021-11-04 | $4.71M derived: sum of 2 quarters · filed 2021-11-04 | $7.38M 10-Q · filed 2021-11-04 | $9.78M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $2.40M 10-Q · filed 2021-08-04 | $5.08M 10-Q · filed 2021-08-04 | $7.47M derived: sum of 3 quarters · filed 2021-08-04 | $9.65M derived: sum of 4 quarters · filed 2021-08-04 | ||||
| 2020-03-31 | $2.67M 10-Q · filed 2021-05-13 | $5.07M derived: sum of 2 quarters · filed 2021-05-13 | $7.25M derived: sum of 3 quarters · filed 2021-05-13 | $9.65M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $4.57M derived: sum of 2 quarters · filed 2021-03-23 | $6.98M derived: sum of 3 quarters · filed 2021-03-23 | $9.08M 10-K · filed 2021-03-23 | ||||
| 2019-09-30 | $2.17M 10-Q · filed 2020-11-13 | $2.17M 10-Q · filed 2019-11-07 | $4.58M derived: sum of 2 quarters · filed 2020-11-13 | $6.68M 10-Q · filed 2020-11-13 | $6.68M 10-Q · filed 2019-11-07 | $9.20M derived: sum of 4 quarters · filed 2020-11-13 | ||
| 2019-06-30 | $2.41M 10-Q · filed 2020-08-13 | $2.41M 10-Q · filed 2019-08-08 | $4.51M 10-Q · filed 2020-08-13 | $4.51M 10-Q · filed 2019-08-08 | $7.03M derived: sum of 3 quarters · filed 2020-08-13 | $9.53M derived: sum of 4 quarters · filed 2020-08-13 | ||
| 2019-03-31 | $2.10M 10-Q · filed 2020-06-18 | $2.10M 10-Q · filed 2019-05-09 | $4.62M derived: sum of 2 quarters · filed 2020-06-18 | $7.13M derived: sum of 3 quarters · filed 2020-06-18 | $9.23M derived: sum of 4 quarters · filed 2020-06-18 | |||
| 2018-12-31 | $2.52M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $5.03M derived: sum of 2 quarters · filed 2020-03-10 | $7.13M derived: sum of 3 quarters · filed 2020-03-10 | $9.48M 10-K · filed 2020-03-10 | ||||
| 2018-09-30 | $2.51M 10-Q · filed 2019-11-07 | $4.60M derived: sum of 2 quarters · filed 2019-11-07 | $6.96M 10-Q · filed 2019-11-07 | $9.43M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | $2.10M 10-Q · filed 2019-08-08 | $4.47M 10-Q · filed 2019-08-08 | $6.92M derived: sum of 3 quarters · filed 2019-08-08 | $9.89M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $2.37M 10-Q · filed 2019-05-09 | $4.82M derived: sum of 2 quarters · filed 2019-05-09 | $7.79M derived: sum of 3 quarters · filed 2019-05-09 | |||||
| 2017-12-31 | $2.46M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $5.42M derived: sum of 2 quarters · filed 2019-03-14 | $12.01M 10-K · filed 2019-03-14 | |||||
| 2017-09-30 | $2.97M 10-Q · filed 2018-11-07 | $9.55M 10-Q · filed 2018-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |